Literature DB >> 28283768

[Ocular involvement in atopic dermatitis : Clinical aspects and therapy].

P Maier1, T Lapp2, T Reinhard2.   

Abstract

Patients with atopic dermatitis frequently complain of ocular symptoms. The general dermatitis can directly affect the periocular skin and patients often present with chronic atopic blepharokeratoconjunctivitis. Early diagnosis of the characteristic ophthalmological alterations, such as blepharitis, allergic conjunctivitis, keratoconjunctivitis sicca, conjunctival scarring with formation of symblepharon and lid malpositioning, filiform keratitis, corneal plaques, (persistent) epithelial defects, corneal ulcers and keratoconus as well as appropriate stage-adapted treatment, including lid hygiene with preservative-free lubricants, topical and sometimes systemic anti-inflammatory therapy and surgical treatment are important for patients to prevent long-term damage of the ocular surface leading to severe visual impairment.

Entities:  

Keywords:  Allergic conjunctivitis; Blepharitis; Diagnosis; Keratitis; Neurodermitis; Treatment

Mesh:

Year:  2017        PMID: 28283768     DOI: 10.1007/s00347-017-0473-3

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  61 in total

1.  Atopic keratoconjunctivitis.

Authors:  M J HOGAN
Journal:  Trans Am Ophthalmol Soc       Date:  1952

2.  Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis.

Authors:  A G Secchi; M S Tognon; A Leonardi
Journal:  Am J Ophthalmol       Date:  1990-12-15       Impact factor: 5.258

3.  Retinal detachments occurring in cataract associated with neurodermatitis.

Authors:  R S COLES; J LAVAL
Journal:  AMA Arch Ophthalmol       Date:  1952-07

4.  Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis.

Authors:  E Nivenius; I van der Ploeg; K Jung; E Chryssanthou; M van Hage; P G Montan
Journal:  Eye (Lond)       Date:  2006-05-05       Impact factor: 3.775

5.  Long-term follow-up of patients with atopic keratoconjunctivitis.

Authors:  W J Power; I Tugal-Tutkun; C S Foster
Journal:  Ophthalmology       Date:  1998-04       Impact factor: 12.079

6.  Topical tacrolimus treatment of atopic eyelid disease.

Authors:  Sarah M Rikkers; Gary N Holland; Gail E Drayton; Franz K Michel; Mark F Torres; Stefani Takahashi
Journal:  Am J Ophthalmol       Date:  2003-03       Impact factor: 5.258

7.  Topical cyclosporine in vernal keratoconjunctivitis.

Authors:  J H Bleik; K F Tabbara
Journal:  Ophthalmology       Date:  1991-11       Impact factor: 12.079

8.  The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis.

Authors:  Y Hu; Y Matsumoto; M Dogru; N Okada; A Igarashi; K Fukagawa; K Tsubota; H Fujishima
Journal:  Allergy       Date:  2007-08       Impact factor: 13.146

9.  Atopic keratoconjunctivitis.

Authors:  C S Foster; M Calonge
Journal:  Ophthalmology       Date:  1990-08       Impact factor: 12.079

10.  Prospective, randomized, double-blind trial to investigate the efficacy and safety of corneal cross-linking to halt the progression of keratoconus.

Authors:  Stefan J Lang; Elisabeth M Messmer; Gerd Geerling; Marc J Mackert; Tobias Brunner; Sylvia Dollak; Borislav Kutchoukov; Daniel Böhringer; Thomas Reinhard; Philip Maier
Journal:  BMC Ophthalmol       Date:  2015-07-21       Impact factor: 2.209

View more
  1 in total

1.  Clinical Observation of Allergic Conjunctival Diseases with Portable and Recordable Slit-Lamp Device.

Authors:  Hiroyuki Yazu; Eisuke Shimizu; Shinri Sato; Naohiko Aketa; Taiichiro Katayama; Ryota Yokoiwa; Yasunori Sato; Kazumi Fukagawa; Yoko Ogawa; Kazuo Tsubota; Hiroshi Fujishima
Journal:  Diagnostics (Basel)       Date:  2021-03-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.